Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

PJ Online | Announcements

Home > PJ > Products | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 268 No 7186 p240
23 February 2002

This article
Reprint
Photocopy


Products

    Announcements

Announcements

Cetraben Emollient cream

Sankyo Pharma UK wishes to inform customers that Cetraben cream (discontinued) and Cetraben Emollient cream have identical formulations.

Magnets for period pain

LadyCare, a magnetic device to relieve dysmenorrhoea, is available from Magno-Pulse (tel 0117 972 8883). The device was approved last year by the Medical Devices Agency. The company says that the device works by improving circulation in the pelvic region, enabling uterine muscles to work more effectively, and by reducing lactic acid levels, thus preventing muscle cramps and spasms. Further information is available at www.magnopulse.com.

AstraZeneca transfers

The following products have been transferred from AstraZeneca to Dentsply:

? Citanest (prilocaine hydrochloride) 4 per cent injection

? Citanest 3 per cent with Octapressin (felypressin 0.03 units/ml) injection

? Lignostab A (lidocaine hydro-chloride with adrenaline 1 in 80,000) injection

? Xylocaine (lidocaine 2 per cent with adrenaline 1 in 80,000) injection

? Xylotox E80 (lidocaine 2 per cent with adrenaline 1 in 80,000) injection

From 18 February, AstraZeneca will no longer provide medical information for dental local anaesthetic products. From this date, enquiries should be directed to medical information, Dentsply, Hamm Moor Lane, Addlestone, Weybridge, Surrey KT15 2SE (tel 01932 837279).

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal

Citation: The Pharmaceutical Journal URI: 20006118

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.

Visit rpharms.com

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Rate
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.